74 results
Page 3 of 4
8-K
EX-10.2
yqvppw
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.4
1qf 801mlat783zp
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.1
pbvvfrqpwrzz8i4
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.5
dnryln wd0bjiau7
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.3
0pywtju0
13 Dec 22
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
4:09pm
8-K
EX-10.1
5kjh 429d3
26 Jul 22
Entry into a Material Definitive Agreement
4:12pm
8-K
EX-10.2
6zysf 3esx
26 Jul 22
Entry into a Material Definitive Agreement
4:12pm
8-K
EX-10.1
zsnnd7rc45
13 May 22
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
5:12pm
8-K
EX-10.2
2lykxz31xwga6xllw7
13 May 22
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
5:12pm
10-Q
EX-10.1
yjhr 6okr
13 May 21
Quarterly report
9:18am
10-Q
EX-10.2
hijfj0wy58lz8yruzzc
13 May 21
Quarterly report
9:18am